368
Views
20
CrossRef citations to date
0
Altmetric
Articles

Pharmacological Induction of Fetal Hemoglobin Synthesis using Histone Deacetylase Inhibitors

Pages 223-233 | Published online: 04 Sep 2013

References

  • Stamatoyannopoulos, G. and Nienhuis, A.W. (1994) Hemo-globin Switching (W.B. Saunders and Co., Philadelphia).
  • Nute, P.E., Pataryas, H.A. and Stamatoyannopoulos, G. (1973) "The G and A hemoglobin chains during human fetal development", Am. J. Hum. Genet. 25, 271–276.
  • Rochette, J., Craig, J.E. and Them, S.L. (1994) "Fetal hemoglobin levels in adults", Blood Rev. 8, 213–224.
  • Stamatoyannopoulos, G. (1991) "Human hemoglobin switching", Science 252, 383.
  • Grosveld, E, Antoniou, M., Berry, M., de Boer, E., Dillon, N., Ellis, J., Fraser, P., Hurst, J., Imam, A., Meijer, D., et al. (1993) "Regulation of human globin gene switching", Cold Spring Harb. Symp. Quant. Biol. 58, 7–13.
  • Weiss, M.J. and Orkin, S.H. (1995) "GATA transcription factors: key regulators of hematopoiesis", Exp. Hematol. 23, 99–107.
  • Grosveld, F., Antoniou, M., Berry, M., De Boer, E., Dillon, N., Ellis, J., Fraser, P., Hanscombe, O., Hurst, J., Imam, A., et al. (1993) "The regulation of human globin gene switching", Philos. Trans. R. Soc. Lond. B Biol. Sci. 339, 183–191.
  • Wijgerde, M., Grosveld, E and Fraser, P. (1995) "Transcrip-tion complex stability and chromatin dynamics in vivo", Nature 377, 209–213.
  • Bender, M.A., Bulger, M., Close, J. and Groudine, M. (2000) "Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region", Mol. Cell 5, 387–393.
  • Peterson, K.R., Clegg, C.H., Huxley, C., Josephson, B.M., Haugen, H.S., Furukawa, T. and Stamatoyannopoulos, G. (1993) "Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes", Proc. Natl Acad. Sci. USA 90, 7593–7597.
  • Crossley, M., Tsang, A.P., Bieker, J.J. and Orkin, S.H. (1994) "Regulation of the erythroid Kruppel-like factor (EKLF) gene promoter by the erythroid transcription factor GATA-1", J. Biol. Chem. 269, 15440–15444.
  • Guy, L.G., Mei, Q., Perkins, A.C., Orkin, S.H. and Wall, L. (1998) "Erythroid Kruppel-like factor is essential for beta-globin gene expression even in absence of gene competition, but is not sufficient to induce the switch from gamma-globin to beta-globin gene expression", Blood 91, 2259–2263.
  • Miller, I.J. and Bieker, J.J. (1993) "A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins", Mol. Cell. Biol. 13, 2776–2786.
  • Perkins, A.C., Sharpe, A.H. and Orkin, S.H. (1995) "Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF", Nature 375, 318–322.
  • Asano, H. and Stamatoyannopoulos, G. (1998) "Activation of beta-globin promoter by erythroid Kruppel-like factor", Mol. Cell. Biol. 18, 102–109.
  • Asano, H., Li, X.S. and Stamatoyannopoulos, G. (2000) "FKLF-2: a novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes", Blood 95, 3578–3584.
  • Rodgers, G.P. (1997) "Overview of pathophysiology and rationale for treatment of sickle cell anemia", Semin. Hematol. 34, 2–7.
  • Saleh, A.W. and Hillen, H.F. (1997) "Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease", Neth. J. Med. 51, 169–178.
  • Noguchi, C.T., Schechter, A.N. and Rodgers, G.P. (1993) "Sickle cell disease pathophysiology", Baillieres Clin. Haematol. 6, 57–91.
  • Huisman, T.H. and Carver, M.F. (1998) "The beta- and delta-thalassemia repository (Ninth Edition; Part I)", Hemoglobin 22, 169–195.
  • Thein, S.L., Hesketh, C., Taylor, P., Temperley, I.J., Hutchinson, R.M., Old, J.M., Wood, W.G., Clegg, J.B. and Weatherall, D.J. (1990) "Molecular basis for dominantly inherited inclusion body beta-thalassemia", Proc. Natl Acad. Sci. USA 87, 3924–3928.
  • Rund, D. and Rachmilewitz, E. (2001) "Pathophysiology of alpha- and beta-thalassemia: therapeutic implications", Semin. Hematol. 38, 343–349.
  • Schrier, S.L. and Mohandas, N. (1992) "Globin-chain specificity of oxidation-induced changes in red blood cell membrane properties", Blood 79, 1586–1592.
  • Scott, M.D., Rouyer-Fessard, P., Lubin, B.H. and Beuzard, Y. (1990) "Entrapment of purified alpha-hemoglobin chains in normal erythrocytes. A model for beta thalassemia", J. Biol. Chem. 265, 17953–17959.
  • Watson, J.S.A. and Bilello, E.P. (1948) "The significance of the paucity of sickle cells in newborn Negro infants", Am. J. Med. Sci. 215, 419–423.
  • Perrine, R.P., Pembrey, ME., John, P, Perrine, S. and Shoup, F. (1978) "Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects", Ann. Intern. Med. 88, 1–6.
  • Brittenham, G., Lozoff, B., Harris, J.W., Sharma, VS. and Narasimhan, S. (1977) "Sickle cell anemia and trait in a population of southern India", Am. J. Hematol. 2, 25–32.
  • Platt, OS., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. and Kinney, T.R. (1991) "Pain in sickle cell disease. Rates and risk factors", N. Engl. J. Med. 325, 11–16.
  • Platt, OS., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. and Klug, EP. (1994) "Mortality in sickle cell disease. Life expectancy and risk factors for early death", N. Engl. J. Med. 330, 1639–1644.
  • Atweh, G.F. and Loukopoulos, D. (2001) "Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia", Semin. Hematol. 38, 367–373.
  • Faller, D.V. and Perrine, S.P. (1995) "Butyrate in the treatment of sickle cell disease and beta-thalassemia", Curr. Opin. Hematol. 2, 109–117.
  • Olivieri, N.F. (1996) "Reactivation of fetal hemoglobin in patients with beta-thalassemia", Semin. Hematol. 33, 24–42.
  • Stamatoyannopoulos, J.A. and Nienhuis, A.W. (1992) "Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies", Annu. Rev. Med. 43, 497–521.
  • DeSimone, J., Heller, P., Hall, L. and Zwiers, D. (1982) "5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons", Proc. Natl Acad. Sci. USA 79, 4428–4431.
  • Ley, T.J., DeSimone, J., Anagnou, NP., Keller, G.H., Humphries, R.K., Turner, PH., Young, N.S., Keller, P. and Nienhuis, A.W. (1982) "5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia", N. Engl. J. Med. 307, 1469–1475.
  • Papayannopoulou, T., Brice, M. and Stamatoyannopoulos, G. (1977) "Hemoglobin F synthesis in vitro: evidence for control at the level of primitive erythroid stem cells", Proc. Natl Acad. Sci. USA 74, 2923–2927.
  • DeSimone, J., Heller, P, Schimenti, J.C. and Duncan, C.H. (1983) "Fetal hemoglobin production in adult baboons by 5-azacytidine or by phenylhydrazine-induced hemolysis is associated with hypomethylation of globin gene DNA", Prog. Clin. Biol. Res. 134, 489–500.
  • Nienhuis, A.W., Ley, T.J., Humphries, R.K., Young, N.S. and Dover, G. (1985) "Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia", Ann. NY Acad. Sci. 445, 198–211.
  • Ley, T.J. and Nienhuis, A.W. (1985) "Induction of hemo-globin F synthesis in patients with beta thalassemia", Annu. Rev. Med. 36, 485–498.
  • Charache, S., Dover, G., Smith, K., Talbot, C.C., Jr, Moyer, M. and Boyer, S. (1983) "Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex", Proc. Natl Acad. Sci. USA 80, 4842–4846.
  • Dover, G.J., Charache, S., Boyer, S.H., Vogelsang, G. and Moyer, M. (1985) "5-Azacytidine increases HbF production and reduces anemia in sickle cell disease: dose-response analysis of subcutaneous and oral dosage regimens", Blood 66,527–532.
  • Mavilio, F., Giampaolo, A., Care, A., Migliaccio, G., Calandrini, M., Russo, G., Pagliardi, G.L., Mastroberardino, G., Marinucci, M. and Peschle, C. (1983) "Molecular mechanisms of human hemoglobin switching: selective undermethylation and expression of globin genes in embryonic, fetal, and adult erythroblasts", Proc. Natl Acad. Sci. USA 80, 6907–6911.
  • Enver, T., Zhang, J.W., Papayannopoulou, T. and Stamatoyannopoulos, G. (1988) "DNA methylation: a secondary event in globin gene switching?", Genes. Dev. 2, 698–706.
  • Torrealba-de Ron, AT., Papayannopoulou, T., Knapp, US., Fu, M.F., Knitter, G. and Stamatoyannopoulos, G. (1984) "Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine", Blood 63, 201–210.
  • Letvin, N.L., Linch, D.C., Beardsley, G.P., McIntyre, K.W. and Nathan, D.G. (1984) "Augmentation of fetal-hemo-globin production in anemic monkeys by hydroxyurea", N. Engl. J. Med. 310, 869–873.
  • Stamatoyannopoulos, G. and Grosveld, E (2001) Hemoglobin Switching, (W.B. Saunders and Co., Philadelphia).
  • Editorial: (1983) "5-azacytidine for beta-thalassaemia?", Lancet, 1, 36–37.
  • Ley, T.J., Anagnou, NY., Young, N.S., Nienhuis, A.W., DeSimone, J. and Heller, P. (1983) "5-azacytidine for beta thalassaemia?", Lancet 1, 467.
  • Clegg, J.B., Weatherall, D.J. and Bodmer, W.F. (1983) "5-azacytidine for beta-thalassemia?", Lancet 1, 536.
  • Papayannopoulou, T., Torrealba de Ron, A., Veith, R., Knitter, G. and Stamatoyannopoulos, G. (1984) "Arabinosyl-cytosine induces fetal hemoglobin in baboons by perturbing erythroid cell differentiation kinetics", Science 224, 617–619.
  • Veith, R., Papayannopoulou, T., Kurachi, S. and Stamatoyannopoulos, G. (1985) "Treatment of baboon with vinblastine: insights into the mechanisms of pharmacologic stimulation of Hb F in the adult", Blood 66, 456–459.
  • Veith, R., Galanello, R., Papayannopoulou, T. and Stamatoyannopoulos, G. (1985) "Stimulation of F-cell pro-duction in patients with sickle-cell anemia treated with cytarabine or hydroxyurea", N. Engl. J. Med. 313, 1571–1575.
  • Platt, OS., Orkin, S.H., Dover, G., Beardsley, G.P., Miller, B. and Nathan, D.G. (1984) "Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia", J. Clin. Investig. 74, 652–656.
  • Galanello, R, Stamatoyannopoulos, G. and Papayarmopoulou, T. (1988) "Mechanism of Hb F stimulation by S-stage compounds. In vitro studies with bone marrow cells exposed to 5-azacytidine, Ara-C, or hydroxyurea", J. Clin. Investig. 81, 1209–1216.
  • Stamatoyannopoulos, G., Veith, R., Galanello, R. and Papayannopoulou, T. (1985) "Hb F production in stressed erythropoiesis: observations and kinetic models", Ann. NY Acad. Sci. 445, 188–197.
  • Charache, S., Barton, F.B., Moore, RD., Term, M.L., Steinberg, M.H., Dover, G.J., Ballas, S.K., McMahon, R.P., Castro, O. and Orringer, E.P. (1996) "Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switch-ing" agent. The multicenter study of Hydroxyurea in Sickle cell anemia", Medicine (Baltimore) 75, 300–326.
  • Steinberg, M.H., Lu, Z.H., Barton, F.B., Terrin, M.L., Charache, S. and Dover, G.J. (1997) "Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea", Blood 89, 1078–1088.
  • Charache, S. (1997) "Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults", Semin. Hematol. 34, 15–21.
  • Ballas, S.K., Dover, G.J. and Charache, S. (1989) "Effect of hydroxyurea on the rheological properties of sickle erythrocytes in vivo", Am. J. Hematol. 32, 104–111.
  • Adragna, N.C., Fonseca, P. and Lauf, P.K. (1994) "Hydroxy-urea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells", Blood 83, 553–560.
  • Al-Khatti, A., Veith, R.W., Papayannopoulou, T., Fritsch, E.F., Goldwasser, E. and Stamatoyannopoulos, G. (1987) "Stimu-lation of fetal hemoglobin synthesis by erythropoietin in baboons", N. Engl. J. Med. 317, 415–420.
  • Blau, C.A., Constantoulakis, P., Khatti, A., Spadaccino, E., Goldwasser, E., Papayannopoulou, T. and Stamatoyannopoulos, G. (1993) "Fetal hemoglobin in acute and chronic states of erythroid expansion", Blood 81, 227–233.
  • al-Khatti, A., Umemura, T., Clow, J., Abels, R.I., Vance, J., Papayannopoulou, T. and Stamatoyannopoulos, G. (1988) "Erythropoietin stimulates F-reticulocyte formation in sickle cell anemia", Trans. Assoc. Am. Physicians 101, 54–61.
  • Nagel, R.L., Vichinsky, E., Shah, M., Johnson, R., Spadacino, E., Fabry, ME., Mangahas, L., Abel, R. and Stamatoyannopoulos, G. (1993) "F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study", Blood 81, 9–14.
  • Umemura, T., al-Khatti, A., Donahue, RE., Papayarmopoulou, T. and Stamatoyarmopoulos, G. (1989) "Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates", Blood 74, 1571–1576.
  • Kruh, J. (1982) "Effects of sodium butyrate, a new pharmacological agent, on cells in culture", Mol. Cell. Biochem. 42, 65–82.
  • Leder, A. and Leder, P. (1975) "Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells", Cell 5, 319–322.
  • Papayannopoulou, T., Nakamoto, B., Kurachi, S. and Nelson, R. (1987) "Analysis of the erythroid phenotype of HEL cells: clonal variation and the effect of inducers", Blood 70, 1764–1772.
  • Cinder, G.D., VVhitters, M.J. and Pohlman, J.K. (1984) "Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate", Proc. Natl Acad. Sci. USA 81, 3954–3958.
  • Bard, H. and Prosmanne, J. (1985) "Relative rates of fetal hemoglobin and adult hemoglobin synthesis in cord blood of infants of insulin-dependent diabetic mothers", Pediatrics 75, 1143–1147.
  • Perrine, S.P., Greene, ME and Faller, D.V. (1985) "Delay in the fetal globin switch in infants of diabetic mothers", N. Engl. J. Med. 312, 334–338.
  • Perrine, S.P., Rudolph, A., Faller, DV., Roman, C., Cohen, R.A., Chen, S.J. and Kan, Y.W. (1988) "Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching", Proc. Natl Acad. Sci. USA 85, 8540–8542.
  • Constantoulakis, P., Papayannopoulou, T. and Stamatoyannopoulos, G. (1988) "alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adult", Blood 72, 1961–1967.
  • Constantoulakis, P., Knitter, G. and Stamatoyannopoulos, G. (1989) "On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC", Blood 74, 1963–1971.
  • Perrine, S.P., Miller, BA., Faller, DV., Cohen, R.A., Vichinsky, E.P., Hurst, D., Lubin, B.H. and Papayannopoulou, T. (1989) "Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia", Blood 74, 454–459.
  • Perrine, S.P., Cinder, CD., Faller, DN., Dover, G.H., Ikuta, T., Witkowska, HE., Cai, SE, Vichinsky, E.P. and Olivieri, N.F. (1993) "A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders", N. Engl. J. Med. 328, 81–86.
  • Stamatoyannopoulos, G., Blau, C.A., Nakamoto, B., Josephson, B., Li, Q., Liakopoulou, E., Pace, B., Papayannopoulou, T., Brusilow, S.W. and Dover, G. (1994) "Fetal hemoglobin induction by acetate, a product of butyrate catabolism", Blood 84, 3198–3204.
  • Liakopoulou, E., Blau, C.A., Li, Q., Josephson, B., Wolf, J.A., Fournarakis, B., Raisys, V, Dover, G., Papayannopoulou, T. and Stamatoyannopoulos, G. (1995) "Stimulation of fetal hemoglobin production by short chain fatty acids", Blood 86, 3227–3235.
  • Dover, G.J., Brusilow, S. and Charache, S. (1994) "Induction of fetal hemoglobin production in subjects with sickle cell anemia by oral sodium phenylbutyrate", Blood 84, 339–343.
  • Collins, A.F., Pearson, HA., Giardina, P., McDonagh, K.T., Brusilow, S.W. and Dover, G.J. (1995) "Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial", Blood 85, 43–49.
  • Collins, A.F., Dover, G.J. and Luban, N.L. (1994) "Increased fetal hemoglobin production in patients receiving valproic acid for epilepsy", Blood 84, 1690–1691.
  • Little, J.A., Dempsey, N.J., Tuchman, M. and Cinder, CD. (1995) "Metabolic persistence of fetal hemoglobin", Blood 85, 1712–1718.
  • Peters, A., Rohloff, D., Kohlmann, T., Renner, F., Jantschek, G., Kerner, W. and Fehm, H.L. (1998) "Fetal hemoglobin in starvation ketosis of young women", Blood 91, 691–694.
  • Swank, R.A. and Stamatoyannopoulos, G. (1998) "Fetal gene reactivation", Curr. Opin. Genet. Dev. 8, 366–370.
  • Kornberg, RD. (1974) "Chromatin structure: a repeating unit of histones and DNA", Science 184, 868–871.
  • Kornberg, RD. and Lorch, Y. (1999) "Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome", Cell 98, 285–294.
  • Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F. and Richmond, T.J. (1997) "Crystal structure of the nucleosome core particle at 2.8 A resolution", Nature 389, 251–260.
  • Davie, J.R. (1998) "Covalent modifications of histones: expression from chromatin templates", Curr. Opin. Genet. Dev. 8, 173–178.
  • Allfrey, V.G. (1966) "Structural modifications of histones and their possible role in the regulation of ribonucleic acid synthesis", Proc. Can Cancer Conf. 6, 313–335.
  • Pogo, B.G., Allfrey, V.G. and Mirsky, A.E. (1966) "RNA synthesis and histone acetylation during the course of gene activation in lymphocytes", Proc. Natl Acad. Sci. USA 55, 805–812.
  • Sealy, L. and Chalkley, R. (1978) "DNA associated with hyperacetylated histone is preferentially digested by DNase I", Nucleic Acids Res. 5, 1863–1876.
  • Vidali, G., Boffa, L.C., Mann, R.S. and Allfrey, V.G. (1978) "Reversible effects of Na-butyrate on histone acetylation", Biochem. Biophys. Res. Commun. 82, 223–227.
  • Hebbes, T.R., Thorne, A.W. and Crane-Robinson, C. (1988) "A direct link between core histone acetylation and transcriptionally active chromatin", Embo. J. 7, 1395–1402.
  • Struhl, K. (1998) "Histone acetylation and transcriptional regulatory mechanisms", Genes. Dev. 12, 599–606.
  • Luo, R.X. and Dean, D.C. (1999) "Chromatin remodeling and transcriptional regulation", J. Natl Cancer Inst. 91, 1288–1294.
  • Ogryzko, V.V., Schiltz, R.L., Russanova, V, Howard, B.H. and Nakatani, Y. (1996) "The transcriptional coactivators p300 and CBP are histone acetyltransferases", Cell 87, 953–959.
  • Mizzen, C.A., Yang, X.J., Kokubo, T., Brownell, J.E., Bannister, A.J., Owen-Hughes, T., Workman, J., Wang, L., Berger, S.L., Kouzarides, T., Nakatani, Y. and Allis, CD. (1996) "The TAF(II)250 subunit of TFIID has histone acetyltransferase activity", Cell 87, 1261–1270.
  • Kuo, M.H., Brownell, J.E., Sobel, RE., Ranalli, TA., Cook, R.G., Edmondson, D.C., Roth, S.Y. and Allis, CD. (1996) "Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines", Nature 383,269–272.
  • Vettese-Dadey, M., Grant, EA., Hebbes, T.R, Crane- Robinson, C., Allis, CD. and Workman, J.L. (1996) "Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitm", Embo. J. 15,2508–2518.
  • Pazin, M.J. and Kadonaga, J.T. (1997) "What's up and down with histone deacetylation and transcription?", Cell 89, 325–328.
  • Grunstein, M. (1997) "Histone acetylation in chromatin structure and transcription", Nature 389, 349–352.
  • Norton, V.G., Imai, B.S., Yau, P. and Bradbury, E.M. (1989) "Histone acetylation reduces nucleosome core particle linking number change", Cell 57, 449–457.
  • Garcia-Ramirez, M., Rocchini, C. and Ausio, J. (1995) "Modulation of chromatin folding by histone acetylation", J. Biol. Chem. 270, 17923–17928.
  • Bauer, W.R., Hayes, J.J., White, J.H. and Wolffe, A.P. (1994) "Nucleosome structural changes due to acetylation", J. Mol. Biol. 236, 685–690.
  • Gray, S.G. and Ekstrom, T.J. (2001) "The human histone deacetylase family", Exp. Cell. Res. 262, 75–83.
  • Taunton, J., Hassig, C.A. and Schreiber, S.L. (1996) "A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p", Science 272, 408–411.
  • Furukawa, Y., Kawakami, T., Sudo, K., Inazawa, J., Matsumine, A., Akiyama, T. and Nakamura, Y. (1996) "Isolation and mapping of a human gene (RED3L1) that is homologous to RPD3, a transcription factor in Saccharo-myces cerevisiae", Cytogenet. Cell Genet. 73, 130–133.
  • Zeng, Y., Tang, C.M., Yao, Y.L., Yang, W.M. and Seto, E. (1998) "Cloning and characterization of the mouse histone deacetylase-2 gene", J. Biol. Chem. 273, 28921–28930.
  • Hu, E., Chen, Z., Fredrickson, T., Zhu, Y., Kirkpatrick, R., Zhang, G.F., Johanson, K., Sung, C.M., Liu, R. and Winkler, J. (2000) "Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor", J. Biol. Chem. 275, 15254–15264.
  • Buggy, J.J., Sideris, M.L., Mak, P., Lorimer, D.D., McIntosh, B. and Clark, J.M. (2000) "Cloning and characterization of a novel human histone deacetylase, HDAC8", Biochem. J. 350(Pt 1), 199–205.
  • Van den Wyngaert, I., de Vries, W., Kremer, A., Neefs, J., Verhasselt, P., Luyten, W.H. and Kass, S.U. (2000) "Cloning and characterization of human histone deacetylase 8", FEBS Lett. 478, 77–83.
  • Gray, SG. and Ekstrom, T.J. (1998) "Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells", Biochem. Biophys. Res. Commun. 245, 423–427.
  • Dangond, F. and Gullans, S.R. (1998) "Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate", Biochem. Biophys. Res. Commun. 247, 833–837.
  • Wang, A.H., Bertos, N.R, Vezmar, M., Pelletier, N., Crosato, M., Heng, H.H., Th'ng, J., Han, J. and Yang, X.J. (1999) "HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor", Mol. Cell. Biol. 19, 7816–7827.
  • Miska, E.A., Karlsson, C., Langley, E., Nielsen, S.J., Pines, J. and Kouzarides, T. (1999) "HDAC4 deacetylase associates with and represses the MEF2 transcription factor", Embo. J. 18, 5099–5107.
  • Grozinger, C.M., Hassig, C.A. and Schreiber, S.L. (1999) "Three proteins define a class of human histone deacetylases related to yeast Hda1p", Proc. Natl Acad. Sci. USA 96, 4868–4873.
  • Fischle, W., Emiliani, S., Hendzel, M.J., Nagase, T., Nomura, N., Voelter, W. and Verdin, E. (1999) "A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p", J. Biol. Chem. 274, 11713–11720.
  • Dunham, I., Shimizu, N., Roe, B.A., Chissoe, S., Hunt, A.R., Collins, J.E., Bruskiewich, R., Beare, D.M., Clamp, M., Smink, L.J., Ainscough, R., Almeida, J.P., Babbage, A., Bagguley, C., Bailey, J., Barlow, K., Bates, K.N., Beasley, O., Bird, C.P., Blakey, S., Bridgeman, A.M., Buck, D., Burgess, J., Burrill, W.D., O'Brien, K.P., et al. (1999) "The DNA sequence of human chromosome 22", Nature 402, 489–495.
  • Afshar, G. and Murnane, J.P. (1999) "Characterization of a human gene with sequence homology to Saccharomyces cerevisiae 5IR2", Gene 234, 161–168.
  • Frye, R.A. (1999) "Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity", Biochem. Biophys. Res. Commun. 260, 273–279.
  • Frye, R.A. (2000) "Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins", Biochem. Biophys. Res. Commun. 273, 793–798.
  • Guarente, L. (2000) "Sir2 links chromatin silencing, metabolism, and aging", Genes Deo. 14, 1021–1026.
  • Imai, S., Armstrong, C.M., Kaeberlein, M. and Guarente, L. (2000) "Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase", Nature 403, 795–800.
  • Marks, P.A., Richon, V.M. and Rifkind, R.A. (2000) "Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells", J. Natl Cancer Inst. 92, 1210–1216.
  • Heinzel, T., Lavinsky, R.M., Mullen, T.M., Soderstrom, M., Laherty, C.D., Torchia, J., Yang, W.M., Brard, G., Ngo, S.D., Davie, J.R., Seto, E., Eisenman, R.N., Rose, D.W., Glass, C.K. and Rosenfeld, M.G. (1997) "A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression", Nature 387, 43–48.
  • Laherty, C.D., Yang, W.M., Sun, J.M., Davie, J.R., Seto, E. and Eisenman, R.N. (1997) "Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression", Cell 89, 349–356.
  • McCaffrey, PG., Newsome, D.A., Fibach, E., Yoshida, M. and Su, M.S. (1997) "Induction of gamma-globin by histone deacetylase inhibitors", Blood 90, 2075–2083.
  • Skarpidi, E., Cao, H., Heltweg, B., White, BE, Marhenke, R.L., Jung, M. and Stamatoyannopoulos, G. (2003) "Hydrox-amide derivatives of short-chain fatty acids are potent inducers of human fetal globin gene expression", Exp. Hematol. 3, 197–203.
  • Cao, H., Stamatoyannopoulos, G. and Jung, M. (2003) "Induction of human {gamma} globin gene expression by histone deacetylase inhibitors", Blood, 2, 701–709.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.